MyFinsight
Home
About
Contact
avbp: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, AVBP has $326,555K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
326,555
269,506
Total stockholders' equity
304,997
249,870
Total liabilities and stockholders' equity
326,555
269,506
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$20,952K
Short-term investments
$187,594K
Cash and cash
equivalents
$112,672K
Other assets
$180K
Right of use assets -
operating leases
$49K
Long-term investments
$5,108K
Total current assets
$321,218K
Total assets
$326,555K
Total liabilities and
stockholders' equity
$326,555K
Total stockholders'
equity
$304,997K
Total liabilities
$21,558K
Accumulated deficit
-$369,097K
Accumulated other
comprehensive income (loss)
$206K
Additional paid-in capital
$673,884K
Total current
liabilities
$21,558K
Common stock 0.0001 par
value, 200,000,000...
$4K
Operating lease
liabilities
$56K
Accrued expenses
$15,569K
Accounts payable
$5,933K
Buy me a coffee
ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP)